Molecular characterization and functional expression of equine interleukin-1 type I and type II receptor cDNAs

Veterinary Immunology and Immunopathology

Volumn 109, Issue 3-4, 2006, Pages 219-231

  Kirisawa, Rikio ^a   Hashimoto, Norikazu ^a   Tazaki, Mizuho ^a   Yamanaka, Hitoki ^a   Ishii, Risako ^a   Hagiwara, Katsuro ^a   Iwai, Hiroshi ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

Equine; Expression; IL 1RI; IL 1RII; Interleukin 1 receptor; Sequence

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE 1; INTERLEUKIN 1 RECEPTOR TYPE 2; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CLONING; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GROWTH INHIBITION; HORSE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSECT CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TERMINAL SEQUENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BIOLOGICAL ASSAY; CLONING, MOLECULAR; HORSES; INTERLEUKIN-1; MOLECULAR SEQUENCE DATA; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; RECEPTORS, INTERLEUKIN-1 TYPE II; RECOMBINANT PROTEINS; RNA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

ANIMALIA; EQUIDAE; EQUUS CABALLUS; INSECTA;

EID: 29944439974     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2005.08.018     Document Type: Article

References (45)

1. H.R. Alexander, G.M. Doherty, C.M. Buresh, D.J. Venzon, and J.A. Norton A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice J. Exp. Med. 173 1991 1029 1032
2. W.H. Alwan, S.D. Carter, J.B. Dixon, D. Bennett, S.A. May, and G.B. Edwards Inerleukin-1-like activity in synovial fluids and sera of horses with arthritis Res. Vet. Sci. 51 1991 72 77
3. P.E. Auron The interleukin 1 receptor: ligand interactions and signal transduction Cytokine Growth Factor Rev. 9 1998 221 237
4. E. Bourke, A. Cassetti, A. Villa, E. Fadlon, F. Colotta, and A. Mantovani IL-1β scavenging by the type II IL-1 decoy receptor in human neutrophils J. Immunol. 170 2003 5999 6005
5. J. Bristulf, S. Gatti, D. Malinowsky, L. Bjork, A.K. Sundgren, and T. Bartfai Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA Eur. Cytokine Netw. 5 1994 319 330
6. F. Colotta, S. Orlando, E.J. Fadlon, S. Sozzani, C. Matteucci, and A. Mantovani Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells J. Exp. Med. 181 1995 2181 2186
7. F. Colotta, F. Re, M. Muzio, R. Bertini, N. Polentarutti, N. Sironi, J.G. Giri, S.K. Dower, J.E. Sims, and A. Mantovani Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4 Science 261 1993 472 475
8. C.A. Dinarello Biologic basis for Interleukin-1 in disease Blood 87 1996 2095 2147
9. C.A. Dinarello Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation Curr. Opin. Pharmacol. 4 2004 378 385
10. S.K. Dower, J.M. Wignall, K. Schooley, C.J. McMahan, J.L. Jackson, K.S. Prickett, S. Lupton, D. Cosman, and J.E. Sims Retention of ligand binding activity by the extracellular domain of the IL-1 receptor J. Immunol. 142 1989 4314 4320
11. B.E. Drevlow, R. Lovis, M.A. Haag, J.M. Sinacore, C. Jacobs, C. Blosche, A. Landay, L.W. Moreland, and R.M. Pope Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis Arthritis Rheum. 39 1996 257 265
12. A.N. Economides, L.R. Carpenter, J.S. Rudge, V. Wong, E.M. Koehler-Stec, C. Hartnett, E.A. Pyles, X. Xu, T.J. Daly, M.R. Young, J.P. Fandl, F. Lee, S. Carver, J. McNay, K. Bailey, S. Ramakanth, R. Hutabarat, T.T. Huang, C. Radziejewski, G.D. Yancopoulos, and N. Stahl Cytokine traps: multi-component, high-affinity blockers of cytokine action Nat. Med. 9 2003 47 52
13. R. Fernandez-Botran, P.M. Chilton, and Y. Ma Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy Adv. Immunol. 63 1996 269 335
14. D.D. Frisbie, and A.J. Nixon Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage Am. J. Vet. Res. 58 1997 524 530
15. M. Goto, R. Kirisawa, M. Tajima, K. Takahashi, and H. Iwai A bioassay for bovine interleukin-1 by the A375 cell growth inhibition J. Vet. Med. Sci. 57 1995 523 525
16. S.A. Greenfeder, P. Nunes, L. Kwee, M. Labow, R.A. Chizzonite, and G. Ju Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex J. Biol. Chem. 270 1995 13757 13765
17. J. Hardy, A.L. Bertone, S.E. Weisbrode, W.W. Muir, T.M. O'Dorisio, and J. Masty Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints Am. J. Vet. Res. 59 1998 88 100
18. R.P. Hart, C. Liu, A.M. Shadiack, R.J. McCormack, and G.M. Jonakait An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia J. Neuroimmunol. 44 1993 49 56
19. C.A. Jacobs, P.E. Baker, E.R. Roux, K.S. Picha, B. Toivola, S. Waugh, and M.K. Kennedy Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor J. Immunol. 146 1991 2983-2989
20. H. Kato, T. Ohashi, N. Nakamura, Y. Nishimura, T. Watari, R. Goitsuka, H. Tsujimoto, and A. Hasegawa Molecular cloning of equine interleukin-1α and -β cDNAs Vet. Immunol. Immunopathol. 48 1995 221 231
21. R. Kirisawa, T. Fukuda, H. Yamanaka, K. Hagiwara, M. Goto, Y. Obata, T. Yoshino, and H. Iwai Enzymatic amplification and expression of bovine interleukin-1 receptor antagonist cDNA Vet. Immunol. Immunopathol. 62 1998 197 208
22. D. Lang, J. Knop, H. Wesche, U. Raffetseder, R. Kurrle, D. Boraschi, and M.U. Martin The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness J. Immunol. 161 1998 6871 6877
23. M.H. MacDonald, S.M. Stover, N.H. Willits, and H.P. Benton Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1 Am. J. Vet. Res. 53 1992 2278 2285
24. D. Malinowsky, J. Lundkvist, S. Laye, and T. Bartfai Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor FEBS Lett. 429 1998 299 302
25. A. Mantovani, M. Locati, A. Vecchi, S. Sozzani, and P. Allavena Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines Trends Immunol. 22 2001 328 336
26. S. Marmiroli, A. Bavelloni, I. Faenza, A. Sirri, A. Ognibene, V. Cenni, J. Tsukada, Y. Koyama, M. Ruzzene, A. Ferri, P.E. Auron, A. Toker, and N.M. Maraldi Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I FEBS Lett. 438 1998 49 54
27. S.A. May, R.E. Hooke, and P. Lees Inteleukin-1 stimulation of equine articular cells Res. Vet. Sci. 52 1992 342 348
28. C.J. McMahan, J.L. Slack, B. Mosley, D. Cosman, S.D. Lupton, L.L. Brunton, C.E. Grubin, J.M. Wignall, N.A. Jenkins, C.I. Brannan, N.G. Copeland, K. Huebner, C.M. Croce, L.A. Cannizzarro, D. Benjamin, S.K. Dower, M.K. Spriggs, and J.E. Sims A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types EMBO J. 10 1991 2821 2832
29. E.A. Morris, B.S. MacDonald, A.C. Webb, and L.J. Rossenwasser Identification of interleukin-1 in equine osteoarthritic joint effusions Am. J. Vet. Res. 51 1990 59 64
30. S. Nakai, K. Mizuno, M. Kaneko, and Y. Hirai A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line Biochem. Biophys. Res. Commun. 154 1988 1189 1196
31. H. Nielsen, J. Engelbrecht, S. Brunak, and G. von Heijne Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites Protein Eng. 10 1997 1 6
32. R.C. Nowinski, M.E. Lostrom, M.R. Tan, M.R. Stone, and W.N. Burnette The isolation of hybrid cell lines producing monoclonal antibodies against the p15 (E) protein of ecotropic murine leukemia viruses Virology 93 1979 111 126
33. K. Ohlsson, P. Bjork, M. Bergenfeldt, R. Hageman, and R.C. Thompson Interleukin-1 receptor antagonist reduces mortality from endotoxic shock Nature 348 1990 550 552
34. S. Orlando, C. Matteucci, E.J. Fadlon, W.A. Buurman, M.T. Bardella, F. Colotta, M. Introna, and A. Mantovani TNF-α, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells J. Immunol. 158 1997 3861 3868
35. S. Orlando, M. Sironi, G. Bianchi, A.H. Drummond, D. Boraschi, D. Yabes, and A. Mantovani Role of metalloproteases in the release of the IL-1 type II decoy receptor J. Biol. Chem. 272 1997 31764 31769
36. H.L. Preas II, D. Reda, M. Tropea, R.W. Vandivier, S.M. Banks, J.M. Agosti, and A.F. Suffredini Effects of recombinant soluble type 1 interleukin-1 receptor on human inflammatory responses to endotoxin Blood 88 1996 2465 2472
37. D.W. Richardson, and G.R. Dodge Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix-related genes by cultured equine articular chondrocytes Am. J. Vet. Res. 61 2000 624 630
38. H. Schreuder, C. Tardif, S. Trump-Kallmeyer, A. Soffientini, E. Sarubbi, A. Akeson, T. Bowlin, S. Yanofsky, and R.W. Barrett A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist Nature 386 1997 194 200
39. J. Schultz, F. Milpetz, P. Bork, and C.P. Ponting SMART, a simple modular architecture research tool: identification of signalling domains Proc. Natl. Acad. Sci. U.S.A. 95 1998 5857 5864
40. J.E. Sims, R.B. Acres, C.E. Grubin, C.J. McMahan, J.M. Wignall, C.J. March, and S.K. Dower Cloning the interleukin 1 receptor from human T cells Proc. Natl. Acad. Sci. U.S.A. 86 1989 8946 8950
41. J.E. Sims, M.A. Gayle, J.L. Slack, M.R. Alderson, T.A. Bird, J.G. Giri, F. Colotta, F. Re, A. Mantovani, K. Shanebeck, K.H. Grabstein, and S.K. Dower Interleukin-1 signaling occurs exclusively via the type 1 receptor Proc. Natl. Acad. Sci. U.S.A. 90 1993 6155 6159
42. J.E. Sims, C.J. March, D. Cosman, M.B. Widmer, H.R. MacDonald, C.J. McMahan, C.E. Grubin, J.M. Wignall, J.L. Jackson, S.M. Call, D. Friend, A.R. Alpert, S. Gillis, D.L. Urdal, and S.K. Dower cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily Science 241 1988 585 589
43. J.L. Slack, K. Schooley, T.P. Bonnert, J.L. Mitcham, E.E. Qwarnstrom, J.E. Sims, and S.K. Dower Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways J. Biol. Chem. 275 2000 4670 4678
44. D.E. Smith, R. Hanna, D. Friend, H. Moore, H. Chen, A.M. Farese, T.J. MacVittie, G.D. Virca, and J.E. Sims The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action Immunity 18 2003 87 96
45. H. Wesche, D. Neumann, K. Resch, and M.U. Martin Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness FEBS Lett. 391 1996 104 108